Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,215 USD | +5,39% | +6,44% | -83,07% |
23/04 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
01/04 | CNS Pharmaceuticals, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 | CI |
Métier
Nombre d'employés: 4
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01/09/17 |
Director of Finance/CFO | 45 | 13/11/19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/12/17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/01/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/01/18 |
John Climaco
CEO | Chief Executive Officer | 55 | 01/09/17 |
Faith Charles
CHM | Chairman | 62 | 03/01/23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25/06/18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08/05/23 |
Jerzy Gumulka
BRD | Director/Board Member | 75 | 08/11/17 |
Carl Evans
BRD | Director/Board Member | 77 | 09/07/18 |
Amy Mahery
BRD | Director/Board Member | - | 18/01 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 10 634 932 | 9 621 176 ( 90,47 %) | 0 | 90,47 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-83,07% | 2,29 M | |
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |
- Bourse
- Actions
- Action CNSP
- Société CNS Pharmaceuticals, Inc.